Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-JMDB: 300 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
300
Total FAERS Reports
61 (20.3%)
Deaths Reported
76
Hospitalizations
300
As Primary/Secondary Suspect
7
Life-Threatening
1
Disabilities
Prescription
Status

FDA Application: 761075 ·

First Report: 20151203 · Latest Report: 20250814

What Are the Most Common PEGFILGRASTIM-JMDB Side Effects?

#1 Most Reported
Death
51 reports (17.0%)
#2 Most Reported
Product quality issue
21 reports (7.0%)
#3 Most Reported
Drug ineffective
20 reports (6.7%)

All PEGFILGRASTIM-JMDB Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Death 51 17.0% 50 1
Product quality issue 21 7.0% 0 0
Drug ineffective 20 6.7% 3 12
Device leakage 17 5.7% 0 0
Hospitalisation 15 5.0% 1 14
Needle issue 14 4.7% 0 0
Neutropenia 13 4.3% 2 7
Febrile neutropenia 12 4.0% 1 6
Nausea 11 3.7% 1 5
Off label use 11 3.7% 0 0
Device issue 10 3.3% 0 0
Vomiting 10 3.3% 1 8
Pyrexia 9 3.0% 1 7
Device breakage 8 2.7% 0 0
Device defective 8 2.7% 2 2
Device mechanical issue 8 2.7% 0 0
Product storage error 8 2.7% 0 1
Product dose omission issue 7 2.3% 0 1
Device malfunction 6 2.0% 0 0
Diarrhoea 6 2.0% 1 4

Who Reports PEGFILGRASTIM-JMDB Side Effects? Age & Gender Data

Gender: 58.1% female, 41.9% male. Average age: 52.3 years. Most reports from: US. View detailed demographics →

Is PEGFILGRASTIM-JMDB Getting Safer? Reports by Year

YearReportsDeathsHosp.
2015 1 0 1
2018 9 0 2
2019 18 1 5
2020 28 7 13
2021 14 9 3
2022 14 4 2
2023 21 3 9
2024 15 3 3
2025 4 2 2

View full timeline →

What Is PEGFILGRASTIM-JMDB Used For?

IndicationReports
Product used for unknown indication 128
Neutropenia 22
Febrile neutropenia 12
Agranulocytosis 10
Chemotherapy 9
Prophylaxis 9
Breast cancer 7
Neoplasm malignant 7
Ovarian cancer 6
Diffuse large b-cell lymphoma 5

PEGFILGRASTIM-JMDB vs Alternatives: Which Is Safer?

PEGFILGRASTIM-JMDB vs PEGINTERFERON ALFA PEGFILGRASTIM-JMDB vs PEGINTERFERON ALFA-2A PEGFILGRASTIM-JMDB vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B PEGFILGRASTIM-JMDB vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B OR PEGINTERFERON BETA-1A OR PEGINTERFERON LAMBDA-1A PEGFILGRASTIM-JMDB vs PEGINTERFERON ALFA-2B PEGFILGRASTIM-JMDB vs PEGINTERFERON BETA-1A PEGFILGRASTIM-JMDB vs PEGINTRON PEGFILGRASTIM-JMDB vs PEGLOTICASE PEGFILGRASTIM-JMDB vs PEGUNIGALSIDASE ALFA-IWXJ PEGFILGRASTIM-JMDB vs PEGVALIASE-PQPZ

Official FDA Label for PEGFILGRASTIM-JMDB

Official prescribing information from the FDA-approved drug label.